Intravitreal Bevacizumab and Triamcinolone for Treatment of Cystoid Macular Oedema Associated with Chronic Myeloid Leukaemia and Imatinib Therapy

Purpose. To evaluate the efficacy of intravitreal bevacizumab and triamcinolone in the treatment of cystoid macular oedema in a case with chronic myeloid leukaemia on imatinib treatment. Methods. We treated a 78-year-old man with bilateral cystoid macular oedema with intravitreal triamcinolone and s...

Descripción completa

Detalles Bibliográficos
Autores principales: Newcott, Eric K., Ellabban, Abdallah A., Tavassoli, Shokufeh, Sallam, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334426/
https://www.ncbi.nlm.nih.gov/pubmed/25722906
http://dx.doi.org/10.1155/2015/713868
_version_ 1782358186957733888
author Newcott, Eric K.
Ellabban, Abdallah A.
Tavassoli, Shokufeh
Sallam, Ahmed
author_facet Newcott, Eric K.
Ellabban, Abdallah A.
Tavassoli, Shokufeh
Sallam, Ahmed
author_sort Newcott, Eric K.
collection PubMed
description Purpose. To evaluate the efficacy of intravitreal bevacizumab and triamcinolone in the treatment of cystoid macular oedema in a case with chronic myeloid leukaemia on imatinib treatment. Methods. We treated a 78-year-old man with bilateral cystoid macular oedema with intravitreal triamcinolone and subsequent bevacizumab in one eye and intravitreal bevacizumab, alone, in the fellow eye. Results. Serial intravitreal bevacizumab with and without triamcinolone treated cystoid macular oedema in both eyes and improved the vision. Conclusion. Intravitreal bevacizumab and triamcinolone could be viable options to treat cystoid macular oedema due to chronic myeloid leukaemia and imatinib therapy.
format Online
Article
Text
id pubmed-4334426
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-43344262015-02-26 Intravitreal Bevacizumab and Triamcinolone for Treatment of Cystoid Macular Oedema Associated with Chronic Myeloid Leukaemia and Imatinib Therapy Newcott, Eric K. Ellabban, Abdallah A. Tavassoli, Shokufeh Sallam, Ahmed Case Rep Ophthalmol Med Case Report Purpose. To evaluate the efficacy of intravitreal bevacizumab and triamcinolone in the treatment of cystoid macular oedema in a case with chronic myeloid leukaemia on imatinib treatment. Methods. We treated a 78-year-old man with bilateral cystoid macular oedema with intravitreal triamcinolone and subsequent bevacizumab in one eye and intravitreal bevacizumab, alone, in the fellow eye. Results. Serial intravitreal bevacizumab with and without triamcinolone treated cystoid macular oedema in both eyes and improved the vision. Conclusion. Intravitreal bevacizumab and triamcinolone could be viable options to treat cystoid macular oedema due to chronic myeloid leukaemia and imatinib therapy. Hindawi Publishing Corporation 2015 2015-02-04 /pmc/articles/PMC4334426/ /pubmed/25722906 http://dx.doi.org/10.1155/2015/713868 Text en Copyright © 2015 Eric K. Newcott et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Newcott, Eric K.
Ellabban, Abdallah A.
Tavassoli, Shokufeh
Sallam, Ahmed
Intravitreal Bevacizumab and Triamcinolone for Treatment of Cystoid Macular Oedema Associated with Chronic Myeloid Leukaemia and Imatinib Therapy
title Intravitreal Bevacizumab and Triamcinolone for Treatment of Cystoid Macular Oedema Associated with Chronic Myeloid Leukaemia and Imatinib Therapy
title_full Intravitreal Bevacizumab and Triamcinolone for Treatment of Cystoid Macular Oedema Associated with Chronic Myeloid Leukaemia and Imatinib Therapy
title_fullStr Intravitreal Bevacizumab and Triamcinolone for Treatment of Cystoid Macular Oedema Associated with Chronic Myeloid Leukaemia and Imatinib Therapy
title_full_unstemmed Intravitreal Bevacizumab and Triamcinolone for Treatment of Cystoid Macular Oedema Associated with Chronic Myeloid Leukaemia and Imatinib Therapy
title_short Intravitreal Bevacizumab and Triamcinolone for Treatment of Cystoid Macular Oedema Associated with Chronic Myeloid Leukaemia and Imatinib Therapy
title_sort intravitreal bevacizumab and triamcinolone for treatment of cystoid macular oedema associated with chronic myeloid leukaemia and imatinib therapy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334426/
https://www.ncbi.nlm.nih.gov/pubmed/25722906
http://dx.doi.org/10.1155/2015/713868
work_keys_str_mv AT newcotterick intravitrealbevacizumabandtriamcinolonefortreatmentofcystoidmacularoedemaassociatedwithchronicmyeloidleukaemiaandimatinibtherapy
AT ellabbanabdallaha intravitrealbevacizumabandtriamcinolonefortreatmentofcystoidmacularoedemaassociatedwithchronicmyeloidleukaemiaandimatinibtherapy
AT tavassolishokufeh intravitrealbevacizumabandtriamcinolonefortreatmentofcystoidmacularoedemaassociatedwithchronicmyeloidleukaemiaandimatinibtherapy
AT sallamahmed intravitrealbevacizumabandtriamcinolonefortreatmentofcystoidmacularoedemaassociatedwithchronicmyeloidleukaemiaandimatinibtherapy

Ejemplares similares